Literature DB >> 10815123

The global problem of multidrug-resistant tuberculosis: the genie is out of the bottle.

C R Horsburgh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10815123     DOI： 10.1001/jama.283.19.2575

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Will tuberculosis become resistant to all antibiotics?

Authors:  C Dye; M A Espinal
Journal:  Proc Biol Sci       Date:  2001-01-07       Impact factor: 5.349

2.  Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing.

Authors:  Max R O'Donnell; Michelle H Larsen; Tyler S Brown; Paras Jain; Vanisha Munsamy; Allison Wolf; Lorenzo Uccellini; Farina Karim; Tulio de Oliveira; Barun Mathema; William R Jacobs; Alexander Pym
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

3.  A Novel Reporter Phage To Detect Tuberculosis and Rifampin Resistance in a High-HIV-Burden Population.

Authors:  Max R O'Donnell; Alexander Pym; Paras Jain; Vanisha Munsamy; Allison Wolf; Farina Karim; William R Jacobs; Michelle H Larsen
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

4.  Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG.

Authors:  Y Shen; L Shen; P Sehgal; D Zhou; M Simon; M Miller; E A Enimi; B Henckler; L Chalifoux; N Sehgal; M Gastron; N L Letvin; Z W Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.

Authors:  Max R O'Donnell; N Padayatchi; I Master; G Osburn; C R Horsburgh
Journal:  Int J Tuberc Lung Dis       Date:  2009-07       Impact factor: 2.373

6.  Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

Authors:  Patrick K Moonan; Teresa N Quitugua; Janice M Pogoda; Gary Woo; Gerry Drewyer; Behzad Sahbazian; Denise Dunbar; Kenneth C Jost; Charles Wallace; Stephen E Weis
Journal:  BMC Public Health       Date:  2011-01-07       Impact factor: 3.295

7.  Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study.

Authors:  Mercedes C Becerra; Chuan-Chin Huang; Leonid Lecca; Jaime Bayona; Carmen Contreras; Roger Calderon; Rosa Yataco; Jerome Galea; Zibiao Zhang; Sidney Atwood; Ted Cohen; Carole D Mitnick; Paul Farmer; Megan Murray
Journal:  BMJ       Date:  2019-10-24

Review 8.  Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives.

Authors:  Abhijeet Singh; Rajendra Prasad; Viswesvaran Balasubramanian; Nikhil Gupta
Journal:  HIV AIDS (Auckl)       Date:  2020-01-13

9.  Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.

Authors:  Max R O'Donnell; Nesri Padayatchi; Charlotte Kvasnovsky; Lise Werner; Iqbal Master; C Robert Horsburgh
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

10.  Multidrug-resistant Mycobacterium tuberculosis, Bangui, Central African Republic.

Authors:  Laurent X Nouvel; Eric Kassa-Kelembho; Tiago Dos Vultos; Germain Zandanga; Jean Rauzier; Carmen Lafoz; Carlos Martin; Jesus Blazquez; Antoine Talarmin; Brigitte Gicquel
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.